Free antiretrovirals must not be restricted only to treatment-naive patients. Experience in Uganda suggests that restricting access is not the way forward.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16156695.
- Also identified by PMC identifier 1201692.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
In some antiretroviral drug distribution programmes, free drugs are provided only, or preferentially, to patients who are treatment-naive. Colebunders and colleagues argue that such a restricted policy is highly problematic.
Medical subject headings
- Acquired Immunodeficiency Syndrome
- Anti-Retroviral Agents
- Health Services Accessibility